Product Information
RIVASTIGMINE 1.5 MG CAPSULE is a generic product labeled by American Health Packaging, priced at $0.1542 per EA under NDC 60687077701. Its NADAC has been published 122 times since Feb 28, 2024.
The Low Outlier badge above means this manufacturer's average price in the Rivastigmine Tartrate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1.5 mg/1
Manufacturer
American Health PackagingNDC
60687077701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIVASTIGMINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA077130On Market Since
1/1/2024
Pharmacological Classes
Price Statistics
The NADAC for RIVASTIGMINE 1.5 MG CAPSULE has been published 122 times since Feb 28, 2024, and over the history we have for it it has declined 27.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1542 per EA |
|---|---|
| All-time high | $0.2112 (Mar 13, 2024) |
| All-time low | $0.1458 (Jan 21, 2026) |
| 52-week high | $0.1894 |
| 52-week low | $0.1458 |
| Median price | $0.1693 |
| Average price | $0.1722 |
| Largest weekly change | +29.7% (Aug 21, 2024) |
| Weeks tracked | 122 |
| Tracking since | Feb 28, 2024 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIVASTIGMINE 1.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 1.5 MG CAPSULE, manufactured by American Health Packaging, is $0.1542 per EA (NDC 60687077701), effective Jun 24, 2026.
How has the price of RIVASTIGMINE 1.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIVASTIGMINE 1.5 MG CAPSULE has declined 27.0%. It has been tracked across 122 weekly CMS publications since Feb 28, 2024.
What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 1.5 MG CAPSULE?
Since Feb 28, 2024, the NADAC for RIVASTIGMINE 1.5 MG CAPSULE has ranged from a low of $0.1458 (Jan 21, 2026) to a high of $0.2112 (Mar 13, 2024), with a median of $0.1693 per EA.
Are there cheaper alternatives to RIVASTIGMINE 1.5 MG CAPSULE?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RIVASTIGMINE 1.5 MG CAPSULE, is $0.1508 per EA — about 2% below RIVASTIGMINE 1.5 MG CAPSULE.
Who manufactures RIVASTIGMINE 1.5 MG CAPSULE?
RIVASTIGMINE 1.5 MG CAPSULE (NDC 60687077701) is labeled by American Health Packaging, and CMS classifies it as a generic product.
Related Drugs
Same classification